New prescribing guidelines for the management of ADHD

Karalyn Huxhagen 01/04/2025

In order to provide professional advice and support to patients managing their attention deficit hyperactivity disorder (ADHD), pharmacists need to understand mechanism of action of pharmacological treatments, and potential for poor compliance due to adverse reactions, poor tolerance to treatment or an inability to afford the medications. By Karalyn Huxhagen BPharm, FPS, CredPharm (MMR), consultant pharmacist

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Comments
This field is for validation purposes and should be left unchanged.
Has the fuel crisis changed how you get around?*
- I’m taking public transport to work more often
- I’m taking public transport between work sites (eg community pharmacy and aged care) more often
- Colleagues and I are carpooling
- We are cutting back (or considering cutting back) on medicines deliveries
- We have stopped (or are considering stopping) medicines deliveries
- I am sticking closer to home when performing medicines reviews
- I would like to reduce pharmacy-related fuel consumption but it’s not feasible
- No change